Qi Xiao Zhou
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Qi Xiao Zhou
Qi Xiao Zhou has 16 years' experience in China as senior business manager and executive. Mr Zhou is the founding chief executive of Shenzhen Lightning Digital Technology, a company focused on the manufacture and distribution of electronic semiconductor since 2001. Mr Zhou has experience within the public markets in Hong Kong, China and Taiwan and has a wealth of business management and development experience. Mr Zhou has broad connections and experience in the licensing of technologies into the Asian region.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 516th | Orthocell | 10% | 27% |
| 536th | Proteomics International Laboratories | 8% | 26% |
| 1095th | Adisyn | -25% | |
| 1612th | Nuheara | -60% | -44% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 124th |  | Orthocell | $4.3m |
| 131st |  | Nuheara | $3.8m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
| 136th | | Proteomics International Laboratories | $3.2m |
| 137th | | Adisyn | $2.9m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
 | NEWS: Tagged in Board Moves October 25, 2023 | 25 Oct 2023 |
| NEWS: Tagged in Orthocell recruits Fiona Wood | 25 Oct 2023 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 30 Jun 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director | | 2012 - 2023 | 124 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Orthocell | 22 Jan 2021 | Issued | 93,325 | $0.57 | $53,587 | Exercise of options |
| Orthocell | 22 Jan 2021 | Other | 300,000 | $0.57 | $172,260 | Exercise of options |
| Orthocell | 19 Nov 2020 | Other | 54,767 | OtherAs advised by the company: Expiry of Unlisted Warrants | ||
| Orthocell | 14 Oct 2020 | Issued | 400,000 | OtherIssue of options | ||
| Orthocell | 14 Aug 2019 | Issued | 7,780 | $0.48 | $3,696 | OtherDirector remuneration |
Powered by Morningstar ®
